RESEARCH, DEVELOPMENT, AND CLINICAL TRIAL EXPENSES, NET (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended |
|---|---|---|---|
Aug. 31, 2026 |
Jan. 31, 2026 |
Jan. 31, 2026 |
|
| ResearchDevelopmentAndClinicalTrialExpensesNetLineItem [Line Items] | |||
| Grant received from NCI | $ 733,815 | $ 826,158 | |
| Maximum [Member] | |||
| ResearchDevelopmentAndClinicalTrialExpensesNetLineItem [Line Items] | |||
| Additional grants receivable | $ 1,200,000 | $ 1,200,000 | |
| National Cancer Institute [Member] | |||
| ResearchDevelopmentAndClinicalTrialExpensesNetLineItem [Line Items] | |||
| Grant received from NCI | $ 2,000,000.0 |